The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement ...
High costs and shortages are driving demand for unregulated GLP-1 drugs, prompting FDA alerts about counterfeit Ozempic and ...
The funding lapse triggered by the U.S. government shutdown is the latest test for an agency that’s already dealt with ...
Medical experts warn against treating over-the-counter supplements the same as leucovorin, the drug the Trump administration ...
The program is designed to encourage companies to invest in domestic drug production and research by offering faster ...
Learn how the FDA’s new pilot program accelerates generic drug approvals and boosts U.S. pharmaceutical manufacturing.
Conservatives are in revolt over the approval of a new abortion drug by Donald Trump and Robert F. Kennedy Jr.'s Food and ...
The microcap biotech stock had its best day ever after the FDA granted its rare-disease drug a breakthrough designation.
Clinical Trials Arena on MSN
Rare disease drug development in the evolving policy environment
FDA consumer safety officer discussed the challenges of navigating policy and politics in rare diseases at a recent meeting.
Federal regulators are proposing to remove another artificial dye from the U.S. food supply — Orange B, a synthetic color ...
The company was one of many to get letters last month from the US Food and Drug Administration calling out what the agency ...
The U.S. Food and Drug Administration said on Friday that it has launched a new pilot program to speed up the review process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback